Identification of transformation products from β-blocking agents formed in wetland microcosms using LC-Q-ToF

Journal of Mass Spectrometry

Volumn 51, Issue 3, 2016, Pages 207-218

  Svan, Alfred ^a   Hedeland, Mikael ^a,b   Arvidsson, Torbjörn ^a,c   Jasper, Justin T ^d   Sedlak, David L ^d   Pettersson, Curt E ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b NATIONAL VETERINARY INSTITUTE   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

^d 109 McLaughlin Hall   (United States)

Author keywords

atenolol; HRMS; identification; LC QToF; metoprolol; propranolol; transformation products; wetland microcosms

Indexed keywords

BIOACTIVITY; DEGRADATION; IDENTIFICATION (CONTROL SYSTEMS); WETLANDS;

ATENOLOL; HRMS; LC-QTOF; METOPROLOL; PROPRANOLOL; TRANSFORMATION PRODUCTS;

EFFLUENTS;

1 NAPHTHOL; ATENOLOL; DRUG METABOLITE; METOPROLOL; PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PHENOXYPROPANOLAMINE DERIVATIVE;

ARTICLE; CARBOXYLATION; CONSTRUCTED WETLAND; CONTROLLED STUDY; DEAMINATION; DRUG DEGRADATION; DRUG TRANSFORMATION; ELECTROSPRAY MASS SPECTROMETRY; HYDROPHILICITY; HYDROXYLATION; IONIZATION; LIQUID CHROMATOGRAPHY; MICROCOSM; OXIDATION; OZONATION; PHOTODEGRADATION; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY; CHEMISTRY; MASS SPECTROMETRY; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; PROCEDURES; WETLAND;

ADRENERGIC BETA-ANTAGONISTS; CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL MICROBIOLOGY; MASS SPECTROMETRY; MICROBIOTA; PHENOXYPROPANOLAMINES; WETLANDS;

EID: 84960103923     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.3737     Document Type: Article

References (31)

1. B. I. Escher, K. Fenner,. Recent advances in environmental risk assessment of transformation products. Environ. Sci. Technol. 2011, 45, 3835.
2. M. D. Celiz, J. Tso, D. S. Aga,. Pharmaceutical metabolites in the environment: analytical challenges and ecological risks. Environ. Toxicol. Chem. 2009, 28, 2473.
3. P. Bottoni, S. Caroli,. Detection and quantification of residues and metabolites of medicinal products in environmental compartments, food commodities and workplaces: a review. J. Pharm. Biomed. Anal. 2014, 106, 3.
4. M. I. Vasquez, A. Lambrianides, M. Schneider, K. Kümmerer, D. Fatta-Kassinos,. Environmental side effects of pharmaceutical cocktails: what we know and what we should know. J. Hazard. Mater. 2014, 279, 169.
5. T. Kosjek, E. Heath, M. Petrovic, D. Barceló,. Mass spectrometry for identifying pharmaceutical biotransformation products in the environment. TrAC Trends Anal. Chem. 2007, 26, 1076.
6. D. Fatta-Kassinos, S. Meric, A. Nikolaou,. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal. Bioanal. Chem. 2011, 399, 251.
7. E. Lee, S. Lee, J. Park, Y. Kim, J. Cho,. Removal and transformation of pharmaceuticals in wastewater treatment plants and constructed wetlands. Drink. Water Eng. Sci. 2013, 6, 89.
8. J. T. Jasper, M. T. Nguyen, Z. L. Jones, N. S. Ismail, D. L. Sedlak, J. O. Sharp, R. G. Luthy, A. J. Horne, K. L. Nelson,. Unit process wetlands for removal of trace organic contaminants and pathogens from municipal wastewater effluents. Environ. Eng. Sci. 2013, 30, 421.
9. H. Buser, T. Poiger, M. D. Müller,. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ. Sci. Technol. 1998, 32, 3449.
10. V. Matamoros, A. Caselles-Osorio, J. García, J. M. Bayona,. Behaviour of pharmaceutical products and biodegradation intermediates in horizontal subsurface flow constructed wetland. A microcosm experiment. Sci. Total Environ. 2008, 394, 171.
11. J. T. Jasper, D. L. Sedlak,. Phototransformation of wastewater-derived trace organic contaminants in open-water unit process treatment wetlands. Environ. Sci. Technol. 2013, 47, 10781.
12. C. Zwiener, S. Seeger, T. Glauner, F. H. Frimmel,. Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal. Bioanal. Chem. 2002, 372, 569.
13. J. T. Jasper, Z. L. Jones, J. O. Sharp, D. L. Sedlak,. Biotransformation of trace organic contaminants in open-water unit process treatment wetlands. Environ. Sci. Technol. 2014, 48, 5136.
14. M. J. Gómez, S. Herrera, D. Solé, E. García-Calvo, A. R. Fernández-Alba,. Spatio-temporal evaluation of organic contaminants and their transformation products along a river basin affected by urban, agricultural and industrial pollution. Sci. Total Environ. 2012, 420, 134.
15. J. Jeon, D. Kurth, R. Ashauer, J. Hollender,. Comparative toxicokinetics of organic micropollutants in freshwater crustaceans. Environ. Sci. Technol. 2013, 47, 8809.
16. R. M. Borkar, B. Raju, R. Srinivas, P. Patel, S. K. Shetty,. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments. Biomed. Chromatogr. 2012, 26, 720.
17. J. Benner, T. A. Ternes,. Ozonation of metoprolol: elucidation of oxidation pathways and major oxidation products. Environ. Sci. Technol. 2009, 43, 5472.
18. M. Maurer, B. I. Escher, P. Richle, C. Schaffner, a. C. Alder,. Elimination of beta-blockers in sewage treatment plants. Water Res. 2007, 41, 1614.
19. A. R. Ribeiro, C. M. Afonso, P. M. L. Castro, M. E. Tiritan,. Enantioselective biodegradation of pharmaceuticals, alprenolol and propranolol, by an activated sludge inoculum. Ecotoxicol. Environ. Saf. 2013, 87, 108.
20. A. Svan, M. Hedeland, T. Arvidsson, J. T. Jasper, D. L. Sedlak, C. E. Pettersson,. Rapid chiral separation of atenolol, metoprolol, propranolol and the zwitterionic metoprolol acid using supercritical fluid chromatography-tandem mass spectrometry-application to wetland microcosms. J. Chromatogr. A 2015, 1409, 251.
21. J. T. Jasper, Z. L. Jones, J. O. Sharp, D. L. Sedlak,. Nitrate removal in shallow open-water treatment wetlands. Environ. Sci. Technol. 2014, 48, 11512.
22. K. O. Borg, E. Carlsson, K.-J. Hoffmann, T.-E. Jönsson, H. Thorin, B. Wallin,. Metabolism of metoprolol-(3H) in man, the dog and the rat. Acta Pharmacol. Toxicol. (Copenh) 1975, 36, 125.
23. B. Ma, H. Huang, X. Chen, Y. Sun, L. Lin, D. Zhong,. Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana. Acta Pharmacol. Sin. 2007, 28, 1067.
24. K. Uwai, M. Tani, Y. Ohtake, S. Abe, A. Maruko, T. Chiba, Y. Hamaya, Y. Ohkubo, M. Takeshita,. Photodegradation products of propranolol: the structures and pharmacological studies. Life Sci. 2005, 78, 357.
25. Z. Li, M. P. Maier, M. Radke,. Screening for pharmaceutical transformation products formed in river sediment by combining ultrahigh performance liquid chromatography/high resolution mass spectrometry with a rapid data-processing method. Anal. Chim. Acta 2014, 810, 61.
26. T. Walle, T. E. Gaffney,. Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. J. Pharmacol. Exp. Ther. 1972, 182, 83.
27. M. Holcapek, L. Kolárová, M. Nobilis,. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Anal. Bioanal. Chem. 2008, 391, 59.
28. C. N. Manners, D. W. Payling, D. A. Smith,. Lipophilicity of zwitterionic sulphate conjugates of tiaramide, propranolol and 4′-hydroxypropranolol. Xenobiotica 1989, 19, 1387.
29. 2. Appl. Catal. B Environ. 2013, 129, 13.
30. Y. Chen, C. Hu, X. Hu, J. Qu,. Indirect photodegradation of amine drugs in aqueous solution under simulated sunlight. Environ. Sci. Technol. 2009, 43, 2760.
31. C. Marvalin, R. Azerad,. Microbial production of phase I and phase II metabolites of propranolol. Xenobiotica 2011, 41, 175.